A Memorandum of Understanding to speed the development of malaria vaccines has been signed by the US National Institute of Allergy and Infectious Diseases and the Malaria Vaccine Initiative.

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1226, 2000-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The development of candidate HIV vaccines is expected to accelerate with 4 new partnerships between the private and public sectors announced by the US National Institute of Allergy and Infectious Diseases (NIAID)

By  

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

The US National Institute of Allergies and Infectious Diseases has granted $US10 million in funding to pharmaceutical company Baxter Healthcare to develop a vaccine against the coronavirus causing severe acute respiratory syndrome

By  

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Malaria vaccines in development

By Ballou W Ripley  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 489-503

Informa Healthcare

Access to resources Recommend Favorite

Progress in development of a malaria vaccine

By  

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Virosomal technology in malaria vaccine development

By Pluschke Gerd   Tamborrini Marco  

Future Virology, Vol. 5, Iss. 3, 2010-05 ,pp. : 247-250

Future Medicine

Access to resources Recommend Favorite